Table 2 Seroprevalence rates and GMTs of EV71 and CoxA16 neutralizing antibodies among age groups
From: Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China
Neutralizing antibody | 0–6-month-old | 7–11-month-old | 1–3-year-old | 4–5-year-old |
|---|---|---|---|---|
EV71 | Seroprevalence rates (95%CI) | |||
27.8 | 7.5 | 47.5 | 83.8 | |
(23.2-37.8) | (3.5-13.8) | (38.3-56.8) | (73.9-91.1) | |
GMTs (95%CI) | ||||
6.8 | 4.5 | 30.2 | 105.8 | |
(6.1-7.6) | (4.1-5.1) | (19.8-46.0) | (68.2-164.2) | |
CoxA16 | Seroprevalence rates (95%CI) | |||
8.9 | 17.5 | 50.8 | 66.3 | |
(6.2-12.3) | (11.2-25.5) | (41.6-60.0) | (54.8-76.4) | |
GMTs (95%CI) | ||||
4.6 | 5.9 | 12.6 | 16.6 | |
(4.4-4.8) | (5.0-7.0) | (9.9-15.9) | (12.4-22.1) | |